A meta-analysis was performed to assess the accuracy of contrast-enhanced endoscopic ultrasonography (EUS) for distinguishing pancreatic adenocarcinoma from other pancreatic masses. 12 studies were included in the analysis, involving 1,139 patients. The pooled sensitivity and specificity of contrast-enhanced EUS was 94% and 89%, respectively. The authors of the meta-analysis conclude that this technique could be useful in clinical practice.